Nanoparticle Delivery of Artesunate Enhances the Anti-tumor Efficiency by Activating Mitochondria-Mediated Cell Apoptosis

Artemisinin and its derivatives were considered to exert a broad spectrum of anti-cancer activities, and they induced significant anti-cancer effects in tumor cells. Artemisinin and its derivatives could be absorbed quickly, and they were widely distributed, selectively killing tumor cells. Since lo...

Full description

Saved in:
Bibliographic Details
Published inNanoscale research letters Vol. 12; no. 1; pp. 403 - 10
Main Authors Liu, Rui, Yu, Xiwei, Su, Chang, Shi, Yijie, Zhao, Liang
Format Journal Article
LanguageEnglish
Published New York Springer US 01.12.2017
Springer Nature B.V
SpringerOpen
Subjects
Online AccessGet full text
ISSN1931-7573
1556-276X
DOI10.1186/s11671-017-2169-7

Cover

Abstract Artemisinin and its derivatives were considered to exert a broad spectrum of anti-cancer activities, and they induced significant anti-cancer effects in tumor cells. Artemisinin and its derivatives could be absorbed quickly, and they were widely distributed, selectively killing tumor cells. Since low concentrations of artesunate primarily depended on oncosis to induce cell death in tumor cells, its anti-tumor effects were undesirable and limited. To obtain better anti-tumor effects, in this study, we took advantage of a new nanotechnology to design novel artesunate-loaded bovine serum albumin nanoparticles to achieve the mitochondrial accumulation of artesunate and induce mitochondrial-mediated apoptosis. The results showed that when compared with free artesunate’s reliance on oncotic death, artesunate-loaded bovine serum albumin nanoparticles showed higher cytotoxicity and their significant apoptotic effects were induced through the distribution of artesunate in the mitochondria. This finding indicated that artesunate-loaded bovine serum albumin nanoparticles damaged the mitochondrial integrity and activated mitochondrial-mediated cell apoptosis by upregulating apoptosis-related proteins and facilitating the rapid release of cytochrome C.
AbstractList Abstract Artemisinin and its derivatives were considered to exert a broad spectrum of anti-cancer activities, and they induced significant anti-cancer effects in tumor cells. Artemisinin and its derivatives could be absorbed quickly, and they were widely distributed, selectively killing tumor cells. Since low concentrations of artesunate primarily depended on oncosis to induce cell death in tumor cells, its anti-tumor effects were undesirable and limited. To obtain better anti-tumor effects, in this study, we took advantage of a new nanotechnology to design novel artesunate-loaded bovine serum albumin nanoparticles to achieve the mitochondrial accumulation of artesunate and induce mitochondrial-mediated apoptosis. The results showed that when compared with free artesunate’s reliance on oncotic death, artesunate-loaded bovine serum albumin nanoparticles showed higher cytotoxicity and their significant apoptotic effects were induced through the distribution of artesunate in the mitochondria. This finding indicated that artesunate-loaded bovine serum albumin nanoparticles damaged the mitochondrial integrity and activated mitochondrial-mediated cell apoptosis by upregulating apoptosis-related proteins and facilitating the rapid release of cytochrome C.
Artemisinin and its derivatives were considered to exert a broad spectrum of anti-cancer activities, and they induced significant anti-cancer effects in tumor cells. Artemisinin and its derivatives could be absorbed quickly, and they were widely distributed, selectively killing tumor cells. Since low concentrations of artesunate primarily depended on oncosis to induce cell death in tumor cells, its anti-tumor effects were undesirable and limited. To obtain better anti-tumor effects, in this study, we took advantage of a new nanotechnology to design novel artesunate-loaded bovine serum albumin nanoparticles to achieve the mitochondrial accumulation of artesunate and induce mitochondrial-mediated apoptosis. The results showed that when compared with free artesunate's reliance on oncotic death, artesunate-loaded bovine serum albumin nanoparticles showed higher cytotoxicity and their significant apoptotic effects were induced through the distribution of artesunate in the mitochondria. This finding indicated that artesunate-loaded bovine serum albumin nanoparticles damaged the mitochondrial integrity and activated mitochondrial-mediated cell apoptosis by upregulating apoptosis-related proteins and facilitating the rapid release of cytochrome C.
Artemisinin and its derivatives were considered to exert a broad spectrum of anti-cancer activities, and they induced significant anti-cancer effects in tumor cells. Artemisinin and its derivatives could be absorbed quickly, and they were widely distributed, selectively killing tumor cells. Since low concentrations of artesunate primarily depended on oncosis to induce cell death in tumor cells, its anti-tumor effects were undesirable and limited. To obtain better anti-tumor effects, in this study, we took advantage of a new nanotechnology to design novel artesunate-loaded bovine serum albumin nanoparticles to achieve the mitochondrial accumulation of artesunate and induce mitochondrial-mediated apoptosis. The results showed that when compared with free artesunate's reliance on oncotic death, artesunate-loaded bovine serum albumin nanoparticles showed higher cytotoxicity and their significant apoptotic effects were induced through the distribution of artesunate in the mitochondria. This finding indicated that artesunate-loaded bovine serum albumin nanoparticles damaged the mitochondrial integrity and activated mitochondrial-mediated cell apoptosis by upregulating apoptosis-related proteins and facilitating the rapid release of cytochrome C.Artemisinin and its derivatives were considered to exert a broad spectrum of anti-cancer activities, and they induced significant anti-cancer effects in tumor cells. Artemisinin and its derivatives could be absorbed quickly, and they were widely distributed, selectively killing tumor cells. Since low concentrations of artesunate primarily depended on oncosis to induce cell death in tumor cells, its anti-tumor effects were undesirable and limited. To obtain better anti-tumor effects, in this study, we took advantage of a new nanotechnology to design novel artesunate-loaded bovine serum albumin nanoparticles to achieve the mitochondrial accumulation of artesunate and induce mitochondrial-mediated apoptosis. The results showed that when compared with free artesunate's reliance on oncotic death, artesunate-loaded bovine serum albumin nanoparticles showed higher cytotoxicity and their significant apoptotic effects were induced through the distribution of artesunate in the mitochondria. This finding indicated that artesunate-loaded bovine serum albumin nanoparticles damaged the mitochondrial integrity and activated mitochondrial-mediated cell apoptosis by upregulating apoptosis-related proteins and facilitating the rapid release of cytochrome C.
ArticleNumber 403
Author Liu, Rui
Yu, Xiwei
Su, Chang
Shi, Yijie
Zhao, Liang
Author_xml – sequence: 1
  givenname: Rui
  surname: Liu
  fullname: Liu, Rui
  organization: School of Pharmacy, Jinzhou Medical University
– sequence: 2
  givenname: Xiwei
  surname: Yu
  fullname: Yu, Xiwei
  organization: School of Pharmacy, Jinzhou Medical University
– sequence: 3
  givenname: Chang
  surname: Su
  fullname: Su, Chang
  organization: School of Veterinary Medicine, Jinzhou Medical University
– sequence: 4
  givenname: Yijie
  surname: Shi
  fullname: Shi, Yijie
  email: shiyijie119@163.com
  organization: School of Pharmacy, Jinzhou Medical University
– sequence: 5
  givenname: Liang
  surname: Zhao
  fullname: Zhao, Liang
  email: liangzhao79@163.com
  organization: School of Pharmacy, Jinzhou Medical University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28610396$$D View this record in MEDLINE/PubMed
BookMark eNp9kk-P0zAQxSO0iP0DH4ALisSFS8CTxHZ8QapKgZV24QISN8txxq2r1C62U6nfHpd20e5K7Mkj-72fZ-x3WZw577AoXgN5D9CxDxGAcagI8KoGJir-rLgASllVc_brLNeigYpT3pwXlzGuCWk54exFcV53DEgj2EWx_6ac36qQrB6x_ISj3WHYl96Us5AwTk4lLBdupZzGWKYVljOXbJWmjQ_lwhirLTq9L_t9OdPJ7lSyblne2uT1yrshWFXd4mAzZSjnOI7lbOu3yUcbXxbPjRojvjqtV8XPz4sf86_Vzfcv1_PZTaUpa1PVilpQTQUOChQ1fQ01cD6oHo3oNQXVCSNq3TRE5bLTOAgYaoONpoYNQjRXxfWRO3i1lttgNyrspVdW_t3wYSlP40uq2cAQsAOtW2J4j9AaYzTPl5Ne1Jn18cjaTv0GB40uBTU-gD48cXYll34nacs64DQD3p0Awf-eMCa5sVHnd1EO_RQlCCJ4C11zkL59JF37Kbj8VLIBwXjd1kQ8pQJBKSUN7UhWvbnf97-G73KQBfwo0MHHGNBIbVP-S38Yw44SiDwkTh4TJ3Pi5CFxkmcnPHLewZ_y1EdPzFq3xHCv6f-a_gAGE-pp
CitedBy_id crossref_primary_10_1039_D0TB01964J
crossref_primary_10_1016_j_apsb_2022_03_020
crossref_primary_10_1016_j_biopha_2018_03_132
crossref_primary_10_1016_j_ceramint_2022_01_223
crossref_primary_10_1021_acsabm_3c00169
crossref_primary_10_1002_ange_201907388
crossref_primary_10_1002_smll_201907663
crossref_primary_10_1021_acsomega_1c00755
crossref_primary_10_1093_rb_rbae103
crossref_primary_10_1186_s11671_021_03497_z
crossref_primary_10_1016_j_bmcl_2018_05_035
crossref_primary_10_1016_j_canlet_2023_216590
crossref_primary_10_1021_acsomega_0c03361
crossref_primary_10_1007_s13659_018_0162_1
crossref_primary_10_3390_medsci6040100
crossref_primary_10_1039_D2NJ03880C
crossref_primary_10_1016_j_jddst_2024_106577
crossref_primary_10_1002_anie_201907388
crossref_primary_10_1016_j_phrs_2018_09_002
crossref_primary_10_1186_s12951_021_01200_z
crossref_primary_10_1016_j_ijbiomac_2023_125348
crossref_primary_10_2147_IJN_S242032
crossref_primary_10_3390_pharmaceutics12080748
crossref_primary_10_1021_acsnano_2c10830
crossref_primary_10_1039_D4MD00261J
crossref_primary_10_1002_slct_202100819
crossref_primary_10_1080_21691401_2018_1505739
crossref_primary_10_1016_j_actbio_2022_12_071
crossref_primary_10_1186_s11671_018_2445_1
Cites_doi 10.3390/ijms160817394
10.1158/1078-0432.CCR-14-0959
10.1007/s00280-009-1095-5
10.1631/jzus.B1000373
10.1158/0008-5472.CAN-09-3535
10.1007/s10495-014-1051-7
10.18632/oncotarget.3004
10.1016/j.yexcr.2016.06.012
10.2174/138955751512150731113242
10.1371/journal.pone.0094034
10.1016/j.cbi.2014.03.011
10.1007/s13346-015-0246-y
10.2147/IJN.S60764
10.1016/j.biotechadv.2014.07.007
10.1039/C4NR07682F
10.1016/j.ijpharm.2014.01.001
10.3109/10717544.2013.801047
10.1074/jbc.M110.210047
10.1166/jbn.2015.1962
10.1097/CAD.0b013e328364a109
10.1016/j.fct.2011.03.016
10.2147/OTT.S81041
10.2147/IJN.S83402
10.1016/j.blre.2015.03.005
10.18632/oncotarget.2792
10.3892/mmr.2015.3517
10.18632/oncotarget.5422
ContentType Journal Article
Copyright The Author(s). 2017
Nanoscale Research Letters is a copyright of Springer, 2017.
Copyright Springer Nature B.V. Dec 2017
Copyright_xml – notice: The Author(s). 2017
– notice: Nanoscale Research Letters is a copyright of Springer, 2017.
– notice: Copyright Springer Nature B.V. Dec 2017
DBID C6C
AAYXX
CITATION
NPM
7QF
7QO
7QQ
7SC
7SE
7SP
7SR
7TA
7TB
7U5
8BQ
8FD
8FE
8FG
8FH
ABJCF
ABUWG
AEUYN
AFKRA
AZQEC
BBNVY
BENPR
BGLVJ
BHPHI
CCPQU
D1I
DWQXO
F28
FR3
GNUQQ
H8D
H8G
HCIFZ
JG9
JQ2
KB.
KR7
L7M
LK8
L~C
L~D
M7P
P64
PDBOC
PHGZM
PHGZT
PIMPY
PKEHL
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1186/s11671-017-2169-7
DatabaseName Springer Nature OA Free Journals
CrossRef
PubMed
Aluminium Industry Abstracts
Biotechnology Research Abstracts
Ceramic Abstracts
Computer and Information Systems Abstracts
Corrosion Abstracts
Electronics & Communications Abstracts
Engineered Materials Abstracts
Materials Business File
Mechanical & Transportation Engineering Abstracts
Solid State and Superconductivity Abstracts
METADEX
Technology Research Database
ProQuest SciTech Collection
ProQuest Technology Collection
ProQuest Natural Science Collection
Materials Science & Engineering Collection
ProQuest Central (Alumni)
ProQuest One Sustainability
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Technology Collection
ProQuest Natural Science Collection
ProQuest One Community College
ProQuest Materials Science Collection
ProQuest Central
ANTE: Abstracts in New Technology & Engineering
Engineering Research Database
ProQuest Central Student
Aerospace Database
Copper Technical Reference Library
SciTech Premium Collection
Materials Research Database
ProQuest Computer Science Collection
Materials Science Database
Civil Engineering Abstracts
Advanced Technologies Database with Aerospace
Biological Sciences
Computer and Information Systems Abstracts – Academic
Computer and Information Systems Abstracts Professional
Biological Science Database
Biotechnology and BioEngineering Abstracts
Materials Science Collection
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
Publicly Available Content Database
Materials Research Database
ProQuest Central Student
ProQuest Central Essentials
ProQuest Computer Science Collection
Computer and Information Systems Abstracts
SciTech Premium Collection
ProQuest Central China
Materials Business File
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
Engineered Materials Abstracts
Natural Science Collection
Biological Science Collection
ProQuest Central (New)
ANTE: Abstracts in New Technology & Engineering
Aluminium Industry Abstracts
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
Electronics & Communications Abstracts
ProQuest Technology Collection
Ceramic Abstracts
Biological Science Database
Biotechnology and BioEngineering Abstracts
ProQuest One Academic UKI Edition
Solid State and Superconductivity Abstracts
Engineering Research Database
ProQuest One Academic
ProQuest One Academic (New)
Technology Collection
Technology Research Database
Computer and Information Systems Abstracts – Academic
ProQuest One Academic Middle East (New)
Mechanical & Transportation Engineering Abstracts
Materials Science Collection
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Natural Science Collection
ProQuest Central
Aerospace Database
Copper Technical Reference Library
Biotechnology Research Abstracts
ProQuest Central Korea
Materials Science Database
Advanced Technologies Database with Aerospace
ProQuest Materials Science Collection
Civil Engineering Abstracts
ProQuest SciTech Collection
METADEX
Computer and Information Systems Abstracts Professional
Materials Science & Engineering Collection
Corrosion Abstracts
MEDLINE - Academic
DatabaseTitleList
PubMed
Publicly Available Content Database
Publicly Available Content Database


MEDLINE - Academic
Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 3
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 4
  dbid: 8FG
  name: ProQuest Technology Collection
  url: https://search.proquest.com/technologycollection1
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Engineering
EISSN 1556-276X
EndPage 10
ExternalDocumentID oai_doaj_org_article_5c6d6e1e81cc40f7be14fffc7eda0b92
PMC5468175
28610396
10_1186_s11671_017_2169_7
Genre Journal Article
GrantInformation_xml – fundername: Liao’ning Educational Committee
  grantid: L2014339
– fundername: Natural Science Foundation of Liaoning Province
  grantid: 2015020692; 201602337
  funderid: http://dx.doi.org/10.13039/501100005047
– fundername: ;
  grantid: 2015020692; 201602337
– fundername: ;
  grantid: L2014339
GroupedDBID -A0
.4S
.86
.DC
0R~
123
29M
2VQ
2WC
4.4
40G
5VS
6NX
8FE
8FG
8FH
AAFWJ
ABJCF
ABMNI
ACGFO
ACGFS
ACIWK
ACPRK
ADBBV
ADINQ
ADRAZ
AEGXH
AENEX
AEUYN
AFGCZ
AFKRA
AFPKN
AFRAH
AHBYD
AHSBF
AHYZX
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
ARCSS
BAPOH
BBNVY
BCNDV
BENPR
BGLVJ
BGNMA
BHPHI
C1A
C24
C6C
CAG
CCPQU
COF
CS3
D1I
DU5
EBS
EDO
EJD
F5P
GROUPED_DOAJ
GX1
H13
HCIFZ
HH5
HYE
HZ~
I09
IAO
IPNFZ
IZQ
KB.
KDC
KQ8
LK8
M48
M4Y
M7P
MM.
M~E
NU0
O5R
O5S
O9-
OK1
P2P
PDBOC
PGMZT
PIMPY
PROAC
RIG
RNS
RPM
RPX
RSV
SCM
SDH
SOJ
TR2
TSK
TUS
U2A
~KM
AAYXX
CITATION
OVT
PHGZM
PHGZT
NPM
7QF
7QO
7QQ
7SC
7SE
7SP
7SR
7TA
7TB
7U5
8BQ
8FD
ABUWG
AZQEC
DWQXO
F28
FR3
GNUQQ
H8D
H8G
JG9
JQ2
KR7
L7M
L~C
L~D
P64
PKEHL
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
7X8
PUEGO
5PM
ID FETCH-LOGICAL-c564t-49295c59eda1a5fb212177dabef9bc51a89f92c330aa898ced91d2fe3c5f6d993
IEDL.DBID C6C
ISSN 1931-7573
IngestDate Wed Aug 27 01:26:46 EDT 2025
Thu Aug 21 13:55:13 EDT 2025
Thu Sep 04 18:05:26 EDT 2025
Fri Jul 18 06:51:05 EDT 2025
Fri Jul 25 11:17:10 EDT 2025
Wed Feb 19 01:59:58 EST 2025
Tue Jul 01 01:14:00 EDT 2025
Thu Apr 24 23:13:25 EDT 2025
Fri Feb 21 02:34:31 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Nanoparticles
Oncosis
Mitochondrial
Artemisinin
Apoptosis
Language English
License Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c564t-49295c59eda1a5fb212177dabef9bc51a89f92c330aa898ced91d2fe3c5f6d993
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://doi.org/10.1186/s11671-017-2169-7
PMID 28610396
PQID 1955503580
PQPubID 2034687
PageCount 10
ParticipantIDs doaj_primary_oai_doaj_org_article_5c6d6e1e81cc40f7be14fffc7eda0b92
pubmedcentral_primary_oai_pubmedcentral_nih_gov_5468175
proquest_miscellaneous_1909741835
proquest_journals_3196724209
proquest_journals_1955503580
pubmed_primary_28610396
crossref_citationtrail_10_1186_s11671_017_2169_7
crossref_primary_10_1186_s11671_017_2169_7
springer_journals_10_1186_s11671_017_2169_7
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20171200
PublicationDateYYYYMMDD 2017-12-01
PublicationDate_xml – month: 12
  year: 2017
  text: 20171200
PublicationDecade 2010
PublicationPlace New York
PublicationPlace_xml – name: New York
– name: United States
– name: Heidelberg
PublicationTitle Nanoscale research letters
PublicationTitleAbbrev Nanoscale Res Lett
PublicationTitleAlternate Nanoscale Res Lett
PublicationYear 2017
Publisher Springer US
Springer Nature B.V
SpringerOpen
Publisher_xml – name: Springer US
– name: Springer Nature B.V
– name: SpringerOpen
References Zhang, Luo, Li, Tan (CR5) 2015; 8
Besbes, Mirshahi, Pocard, Billard (CR16) 2015; 29
Brahmbhatt, Oppermann, Osterlund, Leber, Andrews (CR19) 2015; 21
Aquino, Perazzo, Maistro (CR11) 2011; 49
Wang, Yang, Chen, Wang, Wang, Luo (CR12) 2014; 219
Williams, Cook (CR15) 2015; 6
Ikoba, Peng, Li, Miller, Yu, Wang (CR24) 2015; 7
Yang, Wang, Wang, Wang, Wang, Chen (CR25) 2014; 32
Du, Zhang, Ma, Ji (CR7) 2010; 65
Smoot, Blechacz, Werneburg, Bronk, Sinicrope, Sirica (CR17) 2010; 70
Yu, Yang, Shi, Su, Liu, Feng, Zhao (CR28) 2015; 10
da Jeong, Song, Lim, Lee, Lim, Nam (CR8) 2015; 6
Yang, Wu (CR1) 2015; 15
Jin, Shen, Zhao, Qin, Liu, Huang (CR6) 2013; 20
Song, Li, Wang, Liao, Zhang (CR26) 2015; 11
Kim, Lee, Kim, Sethi, Ahn (CR2) 2015; 6
Yin, Wang, Wang, Dong, Han, Guan (CR10) 2014; 9
Xu, Li, Peng, Sun, Cheng, Ye (CR9) 2011; 12
Hamacher-Brady, Stein, Turschner, Toegel, Mora, Jennewein (CR13) 2011; 286
Shen, Liu, Zhang, Du, Liang, Song (CR22) 2015; 10
Liu, Zuo, Zuo, Wang (CR3) 2015; 12
Modica-Napolitano, Weissig (CR18) 2015; 16
Pang, Qin, Wu, Wang, Chen (CR20) 2016; 347
Agnihotri, Saraf, Singh, Bigoniya (CR23) 2015; 5
Zhou, Sun, Wang, Chen, Zheng, Lu (CR4) 2013; 24
Kvansakul, Hinds (CR14) 2015; 20
Ibrahim, Ibrahim, Dormoi, Briolant, Pradines, Moreno (CR21) 2014; 464
Zhao, Su, Cui, Shi, Liu, Su (CR27) 2014; 9
JH Du (2169_CR7) 2010; 65
Q Xu (2169_CR9) 2011; 12
N Ibrahim (2169_CR21) 2014; 464
J Agnihotri (2169_CR23) 2015; 5
X Yang (2169_CR1) 2015; 15
S Besbes (2169_CR16) 2015; 29
Y Yang (2169_CR25) 2014; 32
M Jin (2169_CR6) 2013; 20
U Ikoba (2169_CR24) 2015; 7
F Song (2169_CR26) 2015; 11
L Liu (2169_CR3) 2015; 12
E Jeong da (2169_CR8) 2015; 6
MM Williams (2169_CR15) 2015; 6
H Brahmbhatt (2169_CR19) 2015; 21
JS Modica-Napolitano (2169_CR18) 2015; 16
Y Wang (2169_CR12) 2014; 219
X Zhou (2169_CR4) 2013; 24
JY Yin (2169_CR10) 2014; 9
S Shen (2169_CR22) 2015; 10
RL Smoot (2169_CR17) 2010; 70
P Zhang (2169_CR5) 2015; 8
A Hamacher-Brady (2169_CR13) 2011; 286
L Zhao (2169_CR27) 2014; 9
X Yu (2169_CR28) 2015; 10
I Aquino (2169_CR11) 2011; 49
M Kvansakul (2169_CR14) 2015; 20
Y Pang (2169_CR20) 2016; 347
C Kim (2169_CR2) 2015; 6
24704559 - Chem Biol Interact. 2014 Aug 5;219:28-36
26170661 - Int J Nanomedicine. 2015 Jun 30;10:4239-53
26426994 - Oncotarget. 2015 Oct 20;6(32):33046-64
25887155 - Blood Rev. 2015 Sep;29(5):345-50
25109677 - Biotechnol Adv. 2014 Nov 15;32(7):1301-16
25784482 - Oncotarget. 2015 Feb 28;6(6):3519-30
25816175 - Mol Med Rep. 2015 Jul;12(1):1465-72
25838396 - Clin Cancer Res. 2015 Jun 15;21(12):2671-6
25945055 - Onco Targets Ther. 2015 Apr 16;8:845-54
25738364 - Oncotarget. 2015 Feb 28;6(6):4020-35
26648717 - Int J Nanomedicine. 2015 Nov 12;10:7045-56
19690861 - Cancer Chemother Pharmacol. 2010 Apr;65(5):895-902
25398535 - Apoptosis. 2015 Feb;20(2):136-50
26223381 - Drug Deliv Transl Res. 2015 Oct;5(5):489-97
21462379 - J Zhejiang Univ Sci B. 2011 Apr;12(4):247-55
26156539 - Mini Rev Med Chem. 2015;15(12):1011-23
21149439 - J Biol Chem. 2011 Feb 25;286(8):6587-601
24739881 - PLoS One. 2014 Apr 16;9(4):e94034
26301299 - J Biomed Nanotechnol. 2015 Jan;11(1):40-52
25680099 - Nanoscale. 2015 Mar 14;7(10):4291-305
23731485 - Drug Deliv. 2013 Apr-May;20(3-4):127-33
21419820 - Food Chem Toxicol. 2011 Jun;49(6):1335-9
24851048 - Int J Nanomedicine. 2014 May 06;9:2149-56
27327234 - Exp Cell Res. 2016 Oct 1;347(2):251-60
23958790 - Anticancer Drugs. 2013 Oct;24(9):920-7
26230693 - Int J Mol Sci. 2015 Jul 29;16(8):17394-421
24412521 - Int J Pharm. 2014 Apr 10;464(1-2):214-24
20160031 - Cancer Res. 2010 Mar 1;70(5):1960-9
References_xml – volume: 16
  start-page: 17394
  year: 2015
  end-page: 17421
  ident: CR18
  article-title: Treatment strategies that enhance the efficacy and selectivity of mitochondria-targeted anticancer agents
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms160817394
– volume: 21
  start-page: 2671
  year: 2015
  end-page: 2676
  ident: CR19
  article-title: Molecular pathways, leveraging the BCL-2 interactome to kill cancer cells—mitochondrial outer membrane permeabilization and beyond
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-14-0959
– volume: 65
  start-page: 895
  year: 2010
  end-page: 902
  ident: CR7
  article-title: Artesunate induces oncosis-like cell death in vitro and has antitumor activity against pancreatic cancer xenografts in vivo
  publication-title: Cancer Chemother Pharmacol
  doi: 10.1007/s00280-009-1095-5
– volume: 12
  start-page: 1465
  year: 2015
  end-page: 1472
  ident: CR3
  article-title: Artesunate induces apoptosis and inhibits growth of Eca109 and Ec9706 human esophageal cancer cell lines in vitro and in vivo
  publication-title: Mol Med Rep
– volume: 12
  start-page: 247
  year: 2011
  end-page: 255
  ident: CR9
  article-title: Artesunate inhibits growth and induces apoptosis in human osteosarcoma HOS cell line in vitro and in vivo
  publication-title: J Zhejiang Univ Sci B
  doi: 10.1631/jzus.B1000373
– volume: 10
  start-page: 7045
  year: 2015
  end-page: 7056
  ident: CR28
  article-title: Intracellular targeted co-delivery of shMDR1 and gefitinib with chitosan nanoparticles for overcoming multidrug resistance
  publication-title: Int J Nanomedicine
– volume: 6
  start-page: 33046
  year: 2015
  end-page: 33064
  ident: CR8
  article-title: Repurposing the anti-malarial drug artesunate as a novel therapeutic agent for metastatic renal cell carcinoma due to its attenuation of tumor growth, metastasis, and angiogenesis
  publication-title: Oncotarget
– volume: 70
  start-page: 1960
  year: 2010
  end-page: 1969
  ident: CR17
  article-title: A Bax-mediated mechanism for obatoclax-induced apoptosis of cholangiocarcin- oma cells
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-09-3535
– volume: 20
  start-page: 136
  year: 2015
  end-page: 150
  ident: CR14
  article-title: The Bcl-2 family, structures, interactions and targets for drug discovery
  publication-title: Apoptosis
  doi: 10.1007/s10495-014-1051-7
– volume: 6
  start-page: 4020
  year: 2015
  end-page: 4035
  ident: CR2
  article-title: Artesunate suppresses tumor growth and induces apoptosis through the modulation of multiple oncogenic cascades in a chronic myeloid leukemia xenograft mouse model
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.3004
– volume: 347
  start-page: 251
  year: 2016
  end-page: 260
  ident: CR20
  article-title: Artesunate induces ROS-dependent apoptosis via a Bax-mediated intrinsic pathway in Huh-7 and Hep3B cells
  publication-title: Exp Cell Res
  doi: 10.1016/j.yexcr.2016.06.012
– volume: 15
  start-page: 1011
  year: 2015
  end-page: 1023
  ident: CR1
  article-title: Main anti-tumor angiogenesis agents isolated from Chinese herbal medicines
  publication-title: Mini Rev Med Chem
  doi: 10.2174/138955751512150731113242
– volume: 9
  start-page: e94034
  year: 2014
  ident: CR10
  article-title: Subchronic toxicological study of two artemisinin derivatives in dogs
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0094034
– volume: 219
  start-page: 28
  year: 2014
  end-page: 36
  ident: CR12
  article-title: Artesunate induces apoptosis through caspase-dependent and -independent mitochondrial pathways in human myelodysplastic syndrome SKM-1 cells
  publication-title: Chem Biol Interact
  doi: 10.1016/j.cbi.2014.03.011
– volume: 5
  start-page: 489
  year: 2015
  end-page: 497
  ident: CR23
  article-title: Development and evaluation of anti-malarial bio-conjugates, artesunate-loaded nanoerythrosomes
  publication-title: Drug Deliv Transl Res
  doi: 10.1007/s13346-015-0246-y
– volume: 9
  start-page: 2149
  year: 2014
  end-page: 2156
  ident: CR27
  article-title: Preparation of biocompatible heat-labile enterotoxin subunit B-bovine serum albumin nanoparticles for improving tumor-targeted drug delivery via heat-labile enterotoxin subunit B mediation
  publication-title: Int J Nanomedicine
  doi: 10.2147/IJN.S60764
– volume: 32
  start-page: 1301
  year: 2014
  end-page: 1316
  ident: CR25
  article-title: Advances in self-assembled chitosan nanomaterials for drug delivery
  publication-title: Biotechnol Adv
  doi: 10.1016/j.biotechadv.2014.07.007
– volume: 7
  start-page: 4291
  year: 2015
  end-page: 4305
  ident: CR24
  article-title: Nanocarriers in therapy of infectious and inflammatory diseases
  publication-title: Nanoscale
  doi: 10.1039/C4NR07682F
– volume: 464
  start-page: 214
  year: 2014
  end-page: 224
  ident: CR21
  article-title: Albumin-bound nanoparticles of practically water-insoluble antimalarial lead greatly enhance its efficacy
  publication-title: Int J Pharm
  doi: 10.1016/j.ijpharm.2014.01.001
– volume: 20
  start-page: 127
  year: 2013
  end-page: 133
  ident: CR6
  article-title: In vivo study of effects of artesunate nanoliposomes on human hepatocellular carcinoma xenografts in nude mice
  publication-title: Drug Deliv
  doi: 10.3109/10717544.2013.801047
– volume: 286
  start-page: 6587
  year: 2011
  end-page: 6601
  ident: CR13
  article-title: Artesunate activates mitochondrial apoptosis in breast cancer cells via iron-catalyzed lysosomal reactive oxygen species production
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M110.210047
– volume: 11
  start-page: 40
  year: 2015
  end-page: 52
  ident: CR26
  article-title: Nanocomposite hydrogels and their applications in drug delivery and tissue engineering
  publication-title: J Biomed Nanotechnol
  doi: 10.1166/jbn.2015.1962
– volume: 24
  start-page: 920
  year: 2013
  end-page: 927
  ident: CR4
  article-title: Artesunate inhibits the growth of gastric cancer cells through the mechanism of promoting oncosis both in vitro and in vivo
  publication-title: Anticancer Drugs
  doi: 10.1097/CAD.0b013e328364a109
– volume: 49
  start-page: 1335
  year: 2011
  end-page: 1339
  ident: CR11
  article-title: Genotoxicity assessment of the antimalarial compound artesunate in somatic cells of mice
  publication-title: Food Chem Toxicol
  doi: 10.1016/j.fct.2011.03.016
– volume: 8
  start-page: 845
  year: 2015
  end-page: 854
  ident: CR5
  article-title: Artesunate inhibits the growth and induces apoptosis of human gastric cancer cells by downregulating COX-2
  publication-title: Oncol Targets Ther
  doi: 10.2147/OTT.S81041
– volume: 10
  start-page: 4239
  year: 2015
  end-page: 4253
  ident: CR22
  article-title: Compound antimalarial ethosomal cataplasm, preparation, evaluation, and mechanism of penetration enhancement
  publication-title: Int J Nanomedicine
  doi: 10.2147/IJN.S83402
– volume: 29
  start-page: 345
  year: 2015
  end-page: 350
  ident: CR16
  article-title: Strategies targeting apoptosis proteins to improve therapy of chronic lymphocytic leukemia
  publication-title: Blood Rev
  doi: 10.1016/j.blre.2015.03.005
– volume: 6
  start-page: 3519
  year: 2015
  end-page: 3530
  ident: CR15
  article-title: Bcl-2 family proteins in breast development and cancer, could Mcl-1 targeting overcome therapeutic resistance?
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.2792
– volume: 65
  start-page: 895
  year: 2010
  ident: 2169_CR7
  publication-title: Cancer Chemother Pharmacol
  doi: 10.1007/s00280-009-1095-5
– volume: 20
  start-page: 136
  year: 2015
  ident: 2169_CR14
  publication-title: Apoptosis
  doi: 10.1007/s10495-014-1051-7
– volume: 5
  start-page: 489
  year: 2015
  ident: 2169_CR23
  publication-title: Drug Deliv Transl Res
  doi: 10.1007/s13346-015-0246-y
– volume: 9
  start-page: e94034
  year: 2014
  ident: 2169_CR10
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0094034
– volume: 16
  start-page: 17394
  year: 2015
  ident: 2169_CR18
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms160817394
– volume: 347
  start-page: 251
  year: 2016
  ident: 2169_CR20
  publication-title: Exp Cell Res
  doi: 10.1016/j.yexcr.2016.06.012
– volume: 15
  start-page: 1011
  year: 2015
  ident: 2169_CR1
  publication-title: Mini Rev Med Chem
  doi: 10.2174/138955751512150731113242
– volume: 12
  start-page: 247
  year: 2011
  ident: 2169_CR9
  publication-title: J Zhejiang Univ Sci B
  doi: 10.1631/jzus.B1000373
– volume: 464
  start-page: 214
  year: 2014
  ident: 2169_CR21
  publication-title: Int J Pharm
  doi: 10.1016/j.ijpharm.2014.01.001
– volume: 286
  start-page: 6587
  year: 2011
  ident: 2169_CR13
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M110.210047
– volume: 32
  start-page: 1301
  year: 2014
  ident: 2169_CR25
  publication-title: Biotechnol Adv
  doi: 10.1016/j.biotechadv.2014.07.007
– volume: 12
  start-page: 1465
  year: 2015
  ident: 2169_CR3
  publication-title: Mol Med Rep
  doi: 10.3892/mmr.2015.3517
– volume: 6
  start-page: 4020
  year: 2015
  ident: 2169_CR2
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.3004
– volume: 6
  start-page: 33046
  year: 2015
  ident: 2169_CR8
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.5422
– volume: 8
  start-page: 845
  year: 2015
  ident: 2169_CR5
  publication-title: Oncol Targets Ther
  doi: 10.2147/OTT.S81041
– volume: 9
  start-page: 2149
  year: 2014
  ident: 2169_CR27
  publication-title: Int J Nanomedicine
  doi: 10.2147/IJN.S60764
– volume: 219
  start-page: 28
  year: 2014
  ident: 2169_CR12
  publication-title: Chem Biol Interact
  doi: 10.1016/j.cbi.2014.03.011
– volume: 49
  start-page: 1335
  year: 2011
  ident: 2169_CR11
  publication-title: Food Chem Toxicol
  doi: 10.1016/j.fct.2011.03.016
– volume: 6
  start-page: 3519
  year: 2015
  ident: 2169_CR15
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.2792
– volume: 29
  start-page: 345
  year: 2015
  ident: 2169_CR16
  publication-title: Blood Rev
  doi: 10.1016/j.blre.2015.03.005
– volume: 70
  start-page: 1960
  year: 2010
  ident: 2169_CR17
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-09-3535
– volume: 21
  start-page: 2671
  year: 2015
  ident: 2169_CR19
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-14-0959
– volume: 10
  start-page: 4239
  year: 2015
  ident: 2169_CR22
  publication-title: Int J Nanomedicine
  doi: 10.2147/IJN.S83402
– volume: 10
  start-page: 7045
  year: 2015
  ident: 2169_CR28
  publication-title: Int J Nanomedicine
– volume: 11
  start-page: 40
  year: 2015
  ident: 2169_CR26
  publication-title: J Biomed Nanotechnol
  doi: 10.1166/jbn.2015.1962
– volume: 20
  start-page: 127
  year: 2013
  ident: 2169_CR6
  publication-title: Drug Deliv
  doi: 10.3109/10717544.2013.801047
– volume: 7
  start-page: 4291
  year: 2015
  ident: 2169_CR24
  publication-title: Nanoscale
  doi: 10.1039/C4NR07682F
– volume: 24
  start-page: 920
  year: 2013
  ident: 2169_CR4
  publication-title: Anticancer Drugs
  doi: 10.1097/CAD.0b013e328364a109
– reference: 26648717 - Int J Nanomedicine. 2015 Nov 12;10:7045-56
– reference: 27327234 - Exp Cell Res. 2016 Oct 1;347(2):251-60
– reference: 21149439 - J Biol Chem. 2011 Feb 25;286(8):6587-601
– reference: 20160031 - Cancer Res. 2010 Mar 1;70(5):1960-9
– reference: 25816175 - Mol Med Rep. 2015 Jul;12(1):1465-72
– reference: 21419820 - Food Chem Toxicol. 2011 Jun;49(6):1335-9
– reference: 23731485 - Drug Deliv. 2013 Apr-May;20(3-4):127-33
– reference: 24851048 - Int J Nanomedicine. 2014 May 06;9:2149-56
– reference: 25398535 - Apoptosis. 2015 Feb;20(2):136-50
– reference: 25738364 - Oncotarget. 2015 Feb 28;6(6):4020-35
– reference: 26426994 - Oncotarget. 2015 Oct 20;6(32):33046-64
– reference: 26170661 - Int J Nanomedicine. 2015 Jun 30;10:4239-53
– reference: 24739881 - PLoS One. 2014 Apr 16;9(4):e94034
– reference: 26156539 - Mini Rev Med Chem. 2015;15(12):1011-23
– reference: 19690861 - Cancer Chemother Pharmacol. 2010 Apr;65(5):895-902
– reference: 25838396 - Clin Cancer Res. 2015 Jun 15;21(12):2671-6
– reference: 26223381 - Drug Deliv Transl Res. 2015 Oct;5(5):489-97
– reference: 26301299 - J Biomed Nanotechnol. 2015 Jan;11(1):40-52
– reference: 26230693 - Int J Mol Sci. 2015 Jul 29;16(8):17394-421
– reference: 23958790 - Anticancer Drugs. 2013 Oct;24(9):920-7
– reference: 24704559 - Chem Biol Interact. 2014 Aug 5;219:28-36
– reference: 25887155 - Blood Rev. 2015 Sep;29(5):345-50
– reference: 21462379 - J Zhejiang Univ Sci B. 2011 Apr;12(4):247-55
– reference: 24412521 - Int J Pharm. 2014 Apr 10;464(1-2):214-24
– reference: 25680099 - Nanoscale. 2015 Mar 14;7(10):4291-305
– reference: 25109677 - Biotechnol Adv. 2014 Nov 15;32(7):1301-16
– reference: 25784482 - Oncotarget. 2015 Feb 28;6(6):3519-30
– reference: 25945055 - Onco Targets Ther. 2015 Apr 16;8:845-54
SSID ssj0047076
Score 2.3324914
Snippet Artemisinin and its derivatives were considered to exert a broad spectrum of anti-cancer activities, and they induced significant anti-cancer effects in tumor...
Abstract Artemisinin and its derivatives were considered to exert a broad spectrum of anti-cancer activities, and they induced significant anti-cancer effects...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
springer
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 403
SubjectTerms Anticancer properties
Apoptosis
Artemisinin
Artesunate
Bovine serum albumin
Cancer
Cattle
Cell death
Chemistry and Materials Science
Cytochrome c
Cytotoxicity
Derivatives
Low concentrations
Materials Science
Mitochondria
Mitochondrial
Molecular Medicine
Nano Express
Nanochemistry
Nanoparticles
Nanoscale Science and Technology
Nanotechnology
Nanotechnology and Microengineering
Oncosis
Proteins
Serum albumin
Stress concentration
Toxicity
Tumor cells
Tumors
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lj9MwELbQnuCAeBNYkJE4gaK1k9iOj2XpaoVUTqy0Nyvxg61UnGqTHvrvmXHSqoUFLtyq2KnsefkbjfMNIe-LIKWVQebWcWxhVmrwOWtzG3QonJS-Yvi98-KrvLyqvlyL64NWX3gnbKQHHgV3Jqx00nNfc2srFlTreRVCsMq7hrU6RV-m2S6ZGmNwpVhqKwfohOdKqHKqZ_JanvVYecAUWuUFlzpXRydSIu6_C23-fmnyl8ppOpAuHpGHE5Kks3EHj8k9H5-QBwf8gk_JFmInJMXjDPrZr_ASxpZ2Ad_y_SYC0KTzeIOa7ylAQTqLwzIfNj-6WzpP5BL4ZSZtt3Rmxz5o8TtdQBCAoBkd2G6-SK0-vKPnfgWLWXfroeuX_TNydTH_dn6ZT70WcitkNYCWCi2s0CBV3ojQwonGlXJN64NureBNrYMubFmyBn7W1jvNXRF8aUWQDkDOc3ISu-hfEhpk2zAP-kcyOeZAc65UkOXViN5UcBlhO3kbOxGRYz-MlUkJSS3NqCIDKjKoIqMy8mH_ynpk4fjb5E-oxP1EJNBOD8CszCRy8y-zysjpzgTM5NW9gQ1BQoeF4zuHMZrBRsEcM_JuPwzuijWYJvpug3_BNBIGlSIjL0aD2i-0qCUW5mVG1JGpHe3keCQubxIluKhkDUAwIx93Rnmw6j8J6tX_ENRrcr9AX0o3fE7JyXC78W8Apw3t2-SSPwGAYTub
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ProQuest Central
  dbid: BENPR
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bb9MwFLZG9wIPE3cCAxmJJ5A152I7fkCoG50mpFYIMWlvUeLLNqkkXdM-9N9zjpOUFcbeotqJ7HPz5x77O4R8SLyURnrJjI2xhFmqweeMYcZrn1gpXcbxvvN0Js_Os28X4mKPzIa7MHiscoiJIVDbxuB_5EdoKgrWE66_LG4YVo3C7OpQQqPsSyvYz4Fi7AHZh5As-IjsH09m338MsTlTPJSbA9QSMyVU2uc541wetZiRwK21YkksNVM7K1Ug9L8Lhf57mPKvjGpYqE4fk4MeYdJxZxJPyJ6rn5JHt3gHn5ENxFTYLHc96Fc3x8MZG9p4fMu16xoAKJ3UV2gRLQWISMcwa7Za_2qWdBJIJ_DGJq02dGy6-mj1JZ1CcIBgWluwaTYNJUCcpSduDoNZNItV0163z8n56eTnyRnrazAwI2S2Au0lWhihnS3jUvgKxBorZcvKeV0ZEZe59joxacpLeMyNszq2iXepEV5aAD8vyKhuaveKUC-rkjuwCySZ49YBUk5BozpHVKe8jQgf5F2YnqAc62TMi7BRyWXRqagAFRWookJF5OP2lUXHznFf52NU4rYjEmuHH5rlZdGLvBBGWuliGJwxGfeqcnHmvTcKBMArnUTkcDCBovf2toAJwUYPE8p3Nv8x3Yi83zaDG2Nupqxds8ZPcI1EQqmIyMvOoLYDTXKJCXsZEbVjajsz2W2pr68CVbjIZA4AMSKfBqO8Ner_Cer1_ZN4Qx4m6CXhTM8hGa2Wa_cWkNmqete722-KOzey
  priority: 102
  providerName: ProQuest
– databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lj9MwELaW5QIHxJvAgozECRRwHrbjA0Jl6WqFVE5U2luU-LFbqeuUJpXov2fGSaotFCRuUexE9jzsbzT2N4S8SZ0QWjgRa5NgCbNMgc9pHWunXGqEsDnD-86zb-J8nn-94BdHZCxvNQiwPRjaYT2p-Xr5_ueP7Sdw-I_B4QvxocVcAgbFMk4ToWJ5i9wO6SI8yZfvkgq5ZKHWHECWJJZcZkOS8-Av9rapwOZ_CIL-eZLyt3Rq2KXO7pN7A7ykk94eHpAj6x-SuzdIBx-RLSyoECn3PegXu8STGVvaOPzKthsP6JNO_RWaQ0sBH9KJ7xZxt7lu1nQaGCfwuiatt3Si--Jo_pLOYGUAYXoDBh3PQv0Pa-ipXcJgVs2qa9pF-5jMz6bfT8_joQBDrLnIO1BdqrjmypoqqbirYZtLpDRVbZ2qNU-qQjmV6ixjFTwW2hqVmNTZTHMnDCCfJ-TYN94-I9SJumIWjAIZ5pixAJMzCaFfgZBOOhMRNsq71AM7ORbJWJYhSilE2auoBBWVqKJSRuTt7pNVT83xr86fUYm7jsiqHV4068tyEHnJtTDCJjA4rXPmZG2T3DmnJQiA1SqNyMloAuVoqSVMCKI8zCYfbMYlDiaaMhWR17tm8GFMzFTeNhv8BVPIIpTxiDztDWo30LQQmK0XEZF7prY3k_0Wv7gKPOE8FwWgw4i8G43yxqj_Jqjn_9X7BbmTotOE8z0n5Lhbb-xLQGld_Sr43i86iTgo
  priority: 102
  providerName: Scholars Portal
Title Nanoparticle Delivery of Artesunate Enhances the Anti-tumor Efficiency by Activating Mitochondria-Mediated Cell Apoptosis
URI https://link.springer.com/article/10.1186/s11671-017-2169-7
https://www.ncbi.nlm.nih.gov/pubmed/28610396
https://www.proquest.com/docview/1955503580
https://www.proquest.com/docview/3196724209
https://www.proquest.com/docview/1909741835
https://pubmed.ncbi.nlm.nih.gov/PMC5468175
https://doaj.org/article/5c6d6e1e81cc40f7be14fffc7eda0b92
Volume 12
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lj9MwELbY3QscEG8Cy8pInEARjhPb8bFbWlZIXSFEpb1FiR9spZJUm_TQf8-Mk1YtFCQuVlU7ke2Zsb_J2N8Q8o57KY30MjY2wRRmqQabMyY2XntupXQZw_vOs2t5Nc--3IibgSwa78Lsx--TXH5sMU6ADq-KeSJ1rE7ImYB1F5V5LMfbRTdTLOSRAziSxEqodAhgHn3FwRYUmPqPwcs_T0n-FioNO9D0EXk4QEc66mX9mNxz9RPyYI9Q8CnZwGIJXnDfgn5ySzx1saGNx6dcu64BWdJJfYuibilgPzqqu0XcrX82d3QS2CTwKiatNnRk-sRn9Q86A6uHVbK2oKzxLOT2cJaO3RI6s2pWXdMu2mdkPp18H1_FQ3KF2AiZdSAWroUR2tkyKYWvYAtLlLJl5byujEjKXHvNTZqyEn7mxlmdWO5daoSXFlDNc3JaN7V7SaiXVckcCBzZ45h1AIFTBW5djnBNeRsRtp3vwgzM45gAY1kEDySXRS-iAkRUoIgKFZH3u0dWPe3GvxpfohB3DZExO_wBilQMU14II610CXTOmIx5Vbkk894bBRPAKs0jcr5VgWIw47aAAYEHh5Hio9W4fMFAOdMReburBvvEoEtZu2aNr2AaGYJSEZEXvULtOspziZF4GRF1oGoHIzmsqRe3gQNcZDIH5BeRD1ul3Ov13ybq1X-1fk3uczSacHbnnJx2d2v3BhBYV12Qk4x9hjKfQnl2Obn--u0i2ONF-KYB5SzLoZzz0S81ES-k
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR3LbtNAcFWlB-CAeGMosEhwAVm1195d76FCaZsqpU2EUCv1Zux9tJWCHeJEKD_HtzHjR2ig9NZb5F1Hs_Mez-wMIe-YE0ILJ3xtQhxhFimQOa197ZRjRggbB3jfeTQWw9P48xk_2yC_urswWFbZ6cRaUZtS4zfybWQVCfYkUJ-mP3ycGoXZ1W6ERtaOVjA7dYux9mLHkV3-hBCu2jncB3q_Z-xgcLI39NspA77mIp4DfExxzZU1WZhxl4MuD6U0WW6dyjUPs0Q5xTTE_Rn8TLQ1KjTM2UhzJ4zCZkxgAjZj_IDSI5u7g_GXr50tiGVQj7cDLyn0JZdRm1cNE7FdYQYEQ3nps1AoX65ZxnqAwHVe77_Fm39lcGvDePCA3G89WtpvWPAh2bDFI3LvSp_Dx2QJOhyC82YH3bcTLAZZ0tLhW7ZaFODw0kFxgRxYUXBJaR-w7M8X38sZHdRNLvCGKM2XtK-beWzFOR2BMgLlXRiQIX9Ujxyxhu7ZCQAzLafzsrqsnpDTW6HGU9IrysI-J9SJPAss8CE2tQuMBc88Ag5SCXqR0hmPBB2-U902RMe5HJO0DowSkTYkSoFEKZIolR75sHpl2nQDuWnzLhJxtREbedcPytl52qI85VoYYUMATus4cDK3Yeyc0xIQEOSKeWSrY4G01S5VCgeCwBIT2Ncu_xEVj7xdLYPawFxQVthygX8RKGxcFHGPPGsYagUoSwQWCAiPyDVWWzvJ-kpxeVG3JuexSMAh9cjHjimvQP0_RL24-RBvyJ3hyeg4PT4cH70kdxlKTF1PtEV689nCvgKvcJ6_bkWPkm-3Le2_AVpIdhU
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF5VRUJwQLxrKLBIcAFZ9Wt3vQeEQpPQUlJxoFJvi72PNlKwQ-wI5a_x65jxIzRQeuvNyq6t2Z1vZmcyszOEvIoc55o77msTYguzWILMae1rJ11kOLdJgPedJ8f84CT5dMpOt8iv_i4MplX2OrFR1KbU-B_5HkJFwHkSyD3XpUV8GY7fz3_42EEKI619O40WIkd29RPct-rd4RB4_TqKxqOv-wd-12HA14wnNdAWSaaZtCYLM-Zy0OOhECbLrZO5ZmGWSicjDT5_Bo-ptkaGJnI21sxxI7EQE6j_GyIGOcFb6uOP_SmQiKBpbAf2UegLJuIuohqmfK_C2Ac68cKPQi59sXEmNq0DLrN3_03b_Ct22xyJ47vkTmfL0kELvntkyxb3ye0LFQ4fkBVob3DL2xl0aGeYBrKipcO3bLUswNSlo-IcsVdRMEbpoKinfr38Xi7oqClvgXdDab6iA912YivO6ATUEKjtwoD0-JOm2Yg1dN_OgJh5Oa_Lalo9JCfXwotHZLsoC7tDqON5FlhAIJazC4wFmzwG7MgU7UfhjEeCfr-V7kqhY0eOmWpcopSrlkUKWKSQRUp45M36lXlbB-SqyR-QieuJWMK7-aFcnKluyxXT3HAbAnFaJ4ETuQ0T55wWsAFBLiOP7PYQUJ1eqRQsCFxKDF1fOvxHSDzycj0MCgOjQFlhyyV-IpBYsihmHnncAmpNaJRyTA3gHhEbUNtYyeZIMT1vipKzhKdginrkbQ_KC1T_b6OeXL2IF-QmyLj6fHh89JTcilBgmkSiXbJdL5b2GZiDdf68kTtKvl23oP8GK-FzsQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Nanoparticle+Delivery+of+Artesunate+Enhances+the+Anti-tumor+Efficiency+by+Activating+Mitochondria-Mediated+Cell+Apoptosis&rft.jtitle=Nanoscale+research+letters&rft.au=Liu%2C+Rui&rft.au=Yu%2C+Xiwei&rft.au=Su%2C+Chang&rft.au=Shi%2C+Yijie&rft.date=2017-12-01&rft.pub=Springer+US&rft.issn=1931-7573&rft.eissn=1556-276X&rft.volume=12&rft.issue=1&rft_id=info:doi/10.1186%2Fs11671-017-2169-7&rft.externalDocID=10_1186_s11671_017_2169_7
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1931-7573&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1931-7573&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1931-7573&client=summon